Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

EISAI

Eisai wins EU licence for kidney cancer drug Kisplyx

Approved as a second-line combination treatment for advanced RCC

Deal Watch August 2016

Pfizer's hat trick as well as Sanofi, GlaxoSmithKline, Boehringer Ingelheim and more are featured in this month's round-up

- PMLiVE

Dept of Health kicks off nationwide sepsis awareness campaign

Hopes to increase public recognition of the condition

- PMLiVE

Exco InTouch appoints president and COO

Steve Powell will lead the mobile healthcare app and data capture firm

- PMLiVE

Pfizer launches app to help patients manage depression

Hopes the Moodivator app will complement treatment and support care teams

DS Biopharma promotes Dr Markus Weissbach

He moves to chief operating officer at the Irish drug discovery firm

Sanofi reception

Sanofi trumpets new IGlarLixi data after regulatory delay

Reports that the combination drug is more effective at controlling glucose than Lantus alone

- PMLiVE

Takeda signs strategic-level outsourcing deal with PRA

R&D deal adds to cutbacks strategy with predicted annual savings of $175m

- PMLiVE

Safe from harm?

Which healthcare systems inspire patient confidence?

- PMLiVE

Horizon swoops on Raptor to add rare disease products

Gains two new orphan medicines through the $800m deal

- PMLiVE

GSK and J&J file sirukumab for rheumatoid arthritis in EU

If approved it will compete with Roche blockbuster Actemra

- PMLiVE

A new era of collaboration

Looking at the factors driving this change and assessing the benefits

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links